Results 91 to 100 of about 731 (176)

Nereid as a regular satellite of Neptune. [PDF]

Sci Adv
Belyakov M, Davis MR, Wong I, Batygin K, Brown ME.   +4 more
europepmc   +1 more source

Neptune's inner moons and rings are exposed icy body interiors. [PDF]

Sci Adv
Davis MR, Belyakov M, Wong I, Milby Z, Brown ME.   +4 more
europepmc   +1 more source

Investing in prostate cancer survivorship. [PDF]

Can Urol Assoc J
Nguyen DD, Wallis CJD.
europepmc   +1 more source

HER1-HER4 expression and co-expression in advanced urothelial carcinoma. [PDF]

ESMO Open
Coca Membribes S, Berney DM, Beltran L, Nally E, Jackson-Spence F, Szabados B, Mariathasan S, Powles T, Ackerman C.   +8 more
europepmc   +1 more source

Immunophenotypic changes following menin inhibition in acute myeloid leukemia. [PDF]

Leukemia
Loghavi S, Farhat A, Jamison TJ, El Hajjar G, Bataller A, Wang SA, Wang W, Tang G, Quesada AE, Bazinet A, Cuglievan B, DiNardo CD, Montalban-Bravo G, Takahashi K, Short NJ, Abbas HA, Kadia T, Ravandi F, Daver N, Jabbour E, Borthakur G, Andreeff M, Medeiros LJ, Kantarjian HM, Issa GC.   +24 more
europepmc   +1 more source

Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102). [PDF]

JCO Oncol Adv
Chen YW, Bobek O, Heller G, Berg S, Tan A, Zhao SG, Galsky M, Rosenberg J, Beltran H, McKay RR.   +9 more
europepmc   +1 more source

Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study. [PDF]

Ann Oncol
Motzer RJ, Albiges L, Treviño Aguirre SA, Kanesvaran R, Centkowski P, Reimers MA, Sade JP, Pouessel D, Biscaldi E, Esteban E, Arranz Arija JÁ, Tykodi SS, van Kooten Losio M, Dighe A, Ma H, Valmeekam V, Simmons A, Scheffold C, Andrianova S, Braun DA, Powles T, Choueiri TK.   +21 more
europepmc   +1 more source

Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801). [PDF]

J Clin Oncol
McKay RR, Ballman KV, Atherton PJ, Ajmera A, Al Baghdadi T, Baumann BC, Beltran H, Berg S, Chen RC, Choudhury AD, Cole S, Jacene HA, Lang JM, Kilari D, Kwok Y, McGregor B, Morris MJ, Parikh M, Swami U, Tan A, Yang YA, Zhang T, Galsky M, Rosenberg J, George D, Choueiri TK.   +25 more
europepmc   +1 more source

Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline Study. [PDF]

JACC Adv
Hills MT, Korjian S, Chi G, Natale A, Saxon L, Ferdinand KC, Kwaku KF, Brancato S, Hughes A, Baca-Motes K, Steinhubl SR, Wessler J, Goldberg N, Asthana A, Shute K, Applebaum J, Doran K, Nikolovski J, Kaul S, Wentworth D, Damaraju CV, Tavakoli C, Patel M, Curtis AB, Spertus JA, Gibson CM, Heartline Executive Committee and Steering Committee.   +26 more
europepmc   +1 more source

Gender Disparities in Citations and Altmetric Attention Score in Oncology. [PDF]

JCO Oncol Pract
Campbell RA, Helstrom E, Chew L, Eapen R, Plimack E, Correa A, Kutikov A, Abbosh P, Calaway A, Nizam A, Gupta S, Psutka SP, Barata P, Dizman N, Sindhani M, Weight CJ, Bukavina L.   +16 more
europepmc   +1 more source